Core Viewpoint - Lishan Health, established in January 2017, aims to drive the development of the health and elderly care industry, aligning with national strategies such as "Healthy China 2030" and focusing on healthcare, elderly care, and biomedicine sectors [3][4][5] Group 1: Company Development - Lishan Health has integrated various resources to enhance service quality and optimize industry structure, achieving total assets exceeding 3 billion yuan [3] - The company has developed a dual focus on health services and biomedicine, establishing itself as an integrated industry operation platform [3] Group 2: Technological Innovation - The company prioritizes technological innovation as a key driver for high-quality industry development, responding to national calls for increased R&D investment and talent development [4] - Lishan Health boasts a strong R&D team, with 52% of its personnel holding advanced technical qualifications, and has made significant advancements in cell and gene therapy [4] - A project on "Immunocellular Drug Production Process Development" has been recognized as a typical innovation case in Shandong Province for 2024, contributing to cost reduction and industry growth [4] Group 3: Social Responsibility - As a state-owned enterprise, Lishan Health emphasizes social responsibility, focusing on public health and actively engaging in community service [5] - The company operates care centers that provide quality elderly care services, alleviating the burden on families and society [5] - In the biomedicine sector, Lishan Health is committed to building a comprehensive industrial chain for cell and gene therapy, establishing a supportive platform for the industry in Jinan [5]